| Literature DB >> 34915313 |
Bichen Miao1, Songbiao Chen1, Xuezhi Zhang1, Peipei Ma1, Mengyu Ma1, Caiyi Chen1, Xiujuan Zhang1, Lingling Chang1, Qian Du1, Yong Huang2, Dewen Tong3.
Abstract
Canine parvovirus-2 (CPV-2) is an important pathogen causing severe diseases in dogs and other wild carnivores. Phosphorylation of NS1 may be related to CPV-2 pathogenicity, but the exact mechanism is unclear. Here, we conducted parvovirus disease surveillance in Shaanxi Province of China and 51 fecal swabs were detected to be infected with CPV-2. The 7 CPV-2 strains were identified, all of which belonged to CPV-2c. The complete genome sequence of one of the strains (CPV-2c XY) was cloned into pKQLL plasmid to construct a full-length infectious clone plasmid pX-CPV-2c, which carried a genetic marker. The plasmid pX-CPV-2c was transfected into F81 cells for virus rescue. And the rescued virus, which was designed as X-CPV-2c, showed the similar biological property to parental CPV-2c XY in vitro and in vivo. We further constructed four NS1 phosphorylation site mutant strains (X-CPV-2cT584A, X-CPV-2cS592A, X-CPV-2cT598A/T601A and X-CPV-2cT617A) on the basis of X-CPV-2c. After the analysis and comparison of biological characteristics, the low pathogenic strain X-CPV-2cT598A/T601A was further screened out, which emphasized the importance of phosphorylation sites 598 T/601 T for the pathogenicity of CPV-2. Overall, our data indicated that T598 and T601, the C-terminal phosphorylation site of CPV-2 NS1, play important roles in viral pathogenicity and laid the foundation for the development of new attenuated live vaccine vectors.Entities:
Keywords: Canine parvovirus-2 (CPV-2); Infectious clone; NS1 phosphorylation; Pathogenicity
Mesh:
Year: 2021 PMID: 34915313 DOI: 10.1016/j.vetmic.2021.109301
Source DB: PubMed Journal: Vet Microbiol ISSN: 0378-1135 Impact factor: 3.293